Sign In
Buy JAZZ
$252.86
-5.52 (-2.14%)
At Close: Jul 31, 2026
JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut
10:26am, Wednesday, 06'th Aug 2025
Jazz shares slide as Q2 loss widens on Chimerix charge, with 2025 sales outlook trimmed despite higher EPS guidance.
Jazz (JAZZ) Q2 Revenue Rises 2%
10:00am, Wednesday, 06'th Aug 2025
Jazz (JAZZ) Q2 Revenue Rises 2%
Jazz Pharmaceuticals plc (JAZZ) Q2 2025 Earnings Call Transcript
05:33am, Wednesday, 06'th Aug 2025
Jazz Pharmaceuticals plc (NASDAQ:JAZZ ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Bruce C. Cozadd - Co-Founder, Chairman & CEO Jack Spinks - Corporate Participant
Jazz (JAZZ) Reports Q2 Earnings: What Key Metrics Have to Say
07:31pm, Tuesday, 05'th Aug 2025
While the top- and bottom-line numbers for Jazz (JAZZ) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wa
Jazz Pharmaceuticals (JAZZ) Reports Q2 Loss, Misses Revenue Estimates
06:16pm, Tuesday, 05'th Aug 2025
Jazz Pharmaceuticals (JAZZ) came out with a quarterly loss of $8.25 per share versus the Zacks Consensus Estimate of a loss of $6.12. This compares to earnings of $5.3 per share a year ago.
Jazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial Guidance
04:05pm, Tuesday, 05'th Aug 2025
– Renee Gala named as President and CEO, effective August 11 – – Total revenues of $1.05 billion in 2Q25 – – Xywav ® revenues grew 13% year-over-year, with robust net patient adds of 625 q
Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline
11:01am, Tuesday, 29'th Jul 2025
Jazz (JAZZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025
04:15pm, Tuesday, 22'nd Jul 2025
DUBLIN , July 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 second quarter financial results on Tuesday, August 5, 2025, after the close
Jazz Pharmaceuticals Names Renee Gala as President and Chief Executive Officer
07:30am, Thursday, 10'th Jul 2025
– Selection Follows Robust Succession Process Led by the Board – – Bruce Cozadd to Retire as CEO and Remain Chairperson of the Board of Directors – DUBLIN , July 10, 2025 /PRNewswire/ -- Jazz
Is JAZZ Stock Undervalued At $110?
10:05am, Monday, 07'th Jul 2025
Jazz Pharmaceuticals (NASDAQ: JAZZ) is currently trading at approximately $110, having decreased by 11% year-to-date, even after a significant positive development with the conditional European Commis
Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor
09:30am, Monday, 07'th Jul 2025
In recent months, Jazz Pharmaceuticals plc has remained a stock that has seen some decline in attention from retail investors. This comes amid the potential approval of Zepzelca in combination with Te
– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial – DUBLIN , July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Eur
Target Action (PDUFA) Date set for October 7, 2025 Application based on data from IMforte, the first Phase 3 trial demonstrating statistically significant and clinically meaningful improvements in bot
First presentation of the Phase 4 XYLO switch study reports blood pressure reductions in patients with narcolepsy when switching from twice-nightly high- to low-sodium oxybate Novel intermediate analy
Why Is Jazz (JAZZ) Up 7.9% Since Last Earnings Report?
12:36pm, Thursday, 05'th Jun 2025
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?
